Biden’s Victory Over Big Pharma Reminder

132

TL/DR –

President Biden’s Inflation Reduction Act has significantly impacted Medicare costs, capping insulin costs at $35 a month and reducing prescription drug costs for seniors. Former President Donald Trump and his allies are strongly opposed to the Inflation Reduction Act, with claims it will raise prescription drug costs for millions of Americans. Additionally, Trump has shown interest in dismantling Obamacare, a move that could potentially impact millions of Americans’ access to healthcare.


DNC Rapid Response Director Alex Floyd stated: “President Biden overcame Big Pharma, benefiting the American public due to the landmark Inflation Reduction Act. This Act has capped insulin costs at $35 a month for millions of Medicare Americans and reduced prescription drug prices for seniors. Trump’s aim to end the Affordable Care Act jeopardizes Americans’ healthcare. President Biden is committed to confronting special interests to lower costs and provide vital care for hardworking families.”

The historic Inflation Reduction Act demands pharmaceutical firms give Medicare rebates for price increases exceeding inflation, caps seniors’ out-of-pocket insulin costs at $35 per month, and offers free adult vaccines to Medicare enrollees.

Major drug companies have agreed to partake in Medicare drug price negotiations. Trump and allies aim to abolish the Inflation Reduction Act, posing a risk to affordable prescription drugs for countless Americans.

Trump continues his relentless attack on health care accessibility for millions of Americans. According to the Daily Beast, Trump’s re-election could lead to the dismantling of Obamacare, a development that would leave 40 million people without health care.

Trump’s supporters on the Hill are keen to reintroduce his plans to repeal the ACA. Discussions on the 2024 campaign trail indicate a willingness to reconsider past efforts to repeal Obamacare. If the GOP regains Senate control, Sen. Mike Crapo (R-Idaho) is open to revisiting the 2017 repeal and replace bills.


Read More US Economic News